MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin

INTRODUCTION: In this secondary analysis of the Metformin and AcaRbose in Chinese as the initial Hypoglycaemic treatment (MARCH) trial, we evaluated what demographic and clinical factors were associated with reduction in weight. We also assessed the effects of acarbose and metformin treatment on wei...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arch Med Sci
Autors principals: Wang, Na, Zhang, Jin-Ping, Xing, Xiao-Yan, Yang, Zhao-Jun, Zhang, Bo, Wang, Xin, Yang, Wen-Ying
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2018
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425198/
https://ncbi.nlm.nih.gov/pubmed/30899282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2018.75255
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars